Marchex, Inc.
NASDAQ:MCHXAdvertising Agencies
+$0.03 today
- Market cap
- $50.00M
- Beta
- 1.89
- P/E (TTM)
- -13.4
- EPS (TTM)
- -$0.11
Volume 0.04M
Average 0.02M
MCHX EBITDA Margin
EBITDA as a percentage of revenue.
Marchex, Inc.NASDAQ: MCHX
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to -9.3%
EBITDA Margin was -9.3% in Q1 FY2026, up 3.8 pp from a year earlier. On a trailing-twelve-month basis it was -6.0%, down 0.2 pp year over year. Over 3 fiscal years it widened by 2.3 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 10.6% for the fiscal year ending Dec 2026, up from -5.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -9.3%+6.2 pp QoQ
- Last fiscal yearDec 2025
- -5.5%-1.7 pp YoY
- LTMMar 2026
- -6.0%-0.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.8 pp | +10.0 pp | +6.2 pp |
| 1 year | -1.7 pp | +16.1 pp | +17.8 pp |
| 3 years | +2.3 pp | — | — |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -5.5%
- Year-over-year change
- -1.7pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -5.5% | -1.7pp |
| FY2024 | 2024-12-31 | -3.7% | +7.8pp |
| FY2023 | 2023-12-31 | -11.5% | -3.8pp |
| FY2022 | 2022-12-31 | -7.7% | -11.2pp |
| FY2021 | 2021-12-31 | 3.5% | — |
EBITDA Margin vs competitors
How MCHX compares with its peers on the latest reported figures
- MCHX's LTM Mar 2026 EBITDA Margin of -6.0% is the 5th highest of the 7 companies compared; the peer median is -2.7%.
- Its year-over-year change of -0.2 pp is the 3rd highest of 6, against a peer median of -13.6 pp.
- Over three fiscal years its change of +2.3 pp compares with a peer median of -14.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 12.4% | +2.9 pp | -1.6 pp | |
| LTM Mar 2026 | 7.5% | -14.1 pp | -8.5 pp | |
| LTM Mar 2026 | 0.1% | +40.7 pp | +11.1 pp | |
| LTM Mar 2026 | -5.6% | -13.6 pp | -21.3 pp | |
| LTM Mar 2026 | -6.0% | -0.2 pp | +2.3 pp | |
| LTM Mar 2026 | -109.9% | -119.8 pp | -116.5 pp | |
| LTM Mar 2026 | -857.4% | — | -484.1 pp | |
| Peer median (excluding MCHX) | -2.7% | -13.6 pp | -14.9 pp | |
Competitors are the stored peer set for MCHX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 53.48M | 52.17M | 49.91M | 48.12M | 45.42M |
| Cost of Revenue | 21.69M | 20.46M | 20.58M | 17.17M | 16.72M |
| Gross Profit | 31.78M | 31.71M | 29.33M | 30.95M | 28.71M |
| Gross Margin | 59.4% | 60.8% | 58.8% | 64.3% | 63.2% |
| Research & Development | 16.11M | 14.36M | 15.36M | 12.41M | 9.75M |
| Selling, General & Admin | 22.84M | 23.3M | 21.62M | 22.38M | 23.33M |
| Operating Expenses | 43.58M | 39.86M | 38.97M | 35.4M | 33.08M |
| Depreciation & Amortization | 5.97M | 4.03M | 3.87M | 2.65M | 2.67M |
| EBITDA | 1.85M | (4.03M) | (5.76M) | (1.8M) | (2.48M) |
| EBITDA Margin | 3.5% | -7.7% | -11.5% | -3.7% | -5.5% |
| Operating Income | (11.8M) | (8.15M) | (9.64M) | (4.45M) | (4.37M) |
| Operating Margin | -22.1% | -15.6% | -19.3% | -9.2% | -9.6% |
| Interest Income | 3K | 99K | 319K | 0 | 0 |
| Interest Expense | 37K | 0 | 293K | 120K | 0 |
| Other Income / Expenses | 7.64M | 88K | (173K) | (120K) | (782K) |
| Income Before Tax | (4.16M) | (8.06M) | (9.82M) | (4.57M) | (5.16M) |
| Pre-Tax Margin | -7.8% | -15.5% | -19.7% | -9.5% | -11.4% |
| Income Tax Expense | 232K | 184K | 94K | 380K | 79K |
| Net Income | (4.39M) | (8.25M) | (9.91M) | (4.95M) | (5.24M) |
| Net Margin | -8.2% | -15.8% | -19.9% | -10.3% | -11.5% |
| EPS (Basic) | (0.10) | (0.19) | (0.23) | (0.11) | (0.12) |
| EPS (Diluted) | (0.10) | (0.19) | (0.23) | (0.11) | (0.11) |
| Weighted Avg Shares | 43.92M | 43.22M | 42.62M | 43.16M | 43.9M |
| Weighted Avg Shares (Diluted) | 43.92M | 43.22M | 42.62M | 43.16M | 48.56M |
Marchex, Inc.
NASDAQ:MCHX
Intrinsic Alpha fair value
Locked
Current Price
$1.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.